Drospirenone/EE vs Placebo for PMDD: RCT
Obstetrics & Gynecology (2005)
Significantly reduced PMDD symptom scores across emotional and physical domains, leading to FDA approval.
How it works
Marek's Guided Optimization® Program combines advanced lab testing, a dedicated health coach and medical provider, and a personalized treatment plan, all built around your data.
Resources
The process
Start your assessment
Complete your 45-min intake assessment
Get your labs drawn
4,000 partnered lab locations nationwide
Review with your coach
Screen-by-screen lab review
Receive your protocol
Treatment delivered to your door
Why Marek
The only program pairing you with a dedicated health coach and medical provider, built on precision diagnostics, with no subscription required.
Resources
Meet our co-founder
Derek
Co-Founder · MPMD Podcast
"Over time, I found it incredibly difficult to get medical oversight for myself and my family that reflected the latest research, and that was preventative. That's why I started Marek Health."

What we test
Every client's lab panel is hand-selected from 1,000+ available biomarkers, built around their specific goals.
Panel categories
Resources
Treatments
700+ medical provider-prescribed therapies built from your labs. Browse by category or explore the full formulary.
Yaz (Drospirenone + Ethinyl Estradiol)
Oral tablet (3mg/0.02mg), 24/4 regimenAvailable in all 50 statesMarketing purposes only. Actual medications, if prescribed, are dispensed by a licensed pharmacy.
hormones
Combined oral contraceptive with drospirenone (spironolactone-derived progestin) offering antimineralocorticoid and antiandrogenic properties. FDA-approved for contraception, PMDD, and acne.
Dual contraception + PMDD management
Antiandrogenic properties reduce acne/hirsutism
Minimizes fluid retention vs other COCs
24/4 dosing reduces hormone-free interval symptoms
No commitment · HSA/FSA eligibleNo commitment · HSA/FSA eligible
How it works
EE suppresses FSH to prevent follicular development; drospirenone suppresses LH to prevent ovulation. Antimineralocorticoid activity blocks aldosterone reducing fluid retention. Antiandrogenic activity reduces sebum and acne.
Every Marek client receives this baseline panel before a provider review. Your provider may add additional biomarkers based on your health history, symptoms, and goals, pulling from 1,000+ available markers. See more biomarkers →
Sex hormones
Adrenals & neurosteroids
Growth hormone / IGF-1
Thyroid hormones
Cardiovascular health
Insulin sensitivity
Liver & pancreas
Kidney function
Comprehensive Metabolic Panel (CMP)
Prostate health
Vitamins & minerals
Iron status
Complete Blood Count (CBC)
Clinical evidence
Obstetrics & Gynecology (2005)
Significantly reduced PMDD symptom scores across emotional and physical domains, leading to FDA approval.
Safety profile
FAQ
Combined oral contraceptive with drospirenone (spironolactone-derived progestin) offering antimineralocorticoid and antiandrogenic properties. FDA-approved for contraception, PMDD, and acne.
Treatments are dependent on licensed clinical prescription. Client costs vary based on individual labs and panel in treatments and services.